Retatrutide / Semaglutide Blend

A research-grade co-formulation combining the targeted GLP-1 mono-agonist semaglutide with the investigational triple GIP/GLP-1/GCGR agonist retatrutide, utilized strictly in preclinical assays to investigate synergistic incretin and metabolic signaling pathways.

• Structure & Synthesis
• Evaluating COAs: HPLC & Mass Spectrometry
• Stability, Solubility & Storage
• Research Comparison
• Key Research Findings Summary
• Analytical Methods Deep Dive

≥99% purity, third-party COA verified, manufactured in the USA. For research use only — not for human or veterinary use.